AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,682,835 | -25.3% | 163,382 | +19.5% | 0.06% | -28.0% |
| Q2 2023 | $2,254,019 | +36.0% | 136,773 | -24.4% | 0.08% | +22.4% |
| Q1 2023 | $1,657,960 | +211.9% | 181,000 | +143.8% | 0.07% | +157.7% |
| Q4 2022 | $531,630 | -65.9% | 74,250 | -68.2% | 0.03% | -67.1% |
| Q4 2020 | $1,561,000 | -24.2% | 233,747 | -42.8% | 0.08% | -43.2% |
| Q3 2020 | $2,059,000 | -60.7% | 408,625 | -36.9% | 0.14% | -57.1% |
| Q2 2020 | $5,233,000 | +729.3% | 647,708 | +741.2% | 0.32% | +881.8% |
| Q4 2017 | $631,000 | -84.7% | 77,000 | -80.3% | 0.03% | -84.1% |
| Q3 2017 | $4,114,000 | -44.0% | 391,839 | -41.2% | 0.21% | -47.7% |
| Q2 2017 | $7,349,000 | -23.9% | 666,316 | -33.2% | 0.40% | -16.6% |
| Q1 2017 | $9,651,000 | – | 997,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |